World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
104
Citations
51425
World Ranking
607
National Ranking
54

Medicine

D-Index
104
Citations
51509
World Ranking
6941
National Ranking
673

Research.com Recognitions

  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom

Overview

Maria Zambon is affiliated with Public Health England in the United Kingdom. Their research primarily focuses on medicine, with particular emphasis on infectious diseases and epidemiology. Their work spans subfields such as modeling and simulation, pulmonary and respiratory medicine, and neurology.

Zambon's research themes center on SARS-CoV-2 and COVID-19, including clinical studies and epidemiological investigations related to the virus. Other significant topics include SARS-CoV-2 detection and testing, respiratory viral infections, influenza virus studies, and viral gastroenteritis research and epidemiology.

The scientist has contributed extensively to several publication venues. Frequent outlets include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • SSRN Electronic Journal
  • Eurosurveillance
  • Journal of Infection
  • Influenza and Other Respiratory Viruses

Among the notable recent papers authored or co-authored by Zambon are:

  • Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR, 2020, Eurosurveillance
  • Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant, 2021, New England Journal of Medicine
  • Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020, 2020, Eurosurveillance
  • COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study, 2021, The Lancet
  • Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study, 2021, The Lancet Infectious Diseases

Zambon collaborates regularly with several researchers, including Mary Ramsay, Joanna Ellis, Jamie Lopez Bernal, Meera Chand, and Kevin Brown.

Throughout their career, they have been recognized as a Fellow of The Academy of Medical Sciences, United Kingdom.

Best Publications

  • Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR.

    Victor M. Corman;Olfert Landt;Marco Kaiser;Richard Molenkamp

  • Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.

    Jamielopez L. Bernal;Nick Andrews;Charlotte Gower;Eileen Gallagher

  • Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group.

    Raoul J. de Groot;Susan C. Baker;Ralph S. Baric;Caroline S. Brown

  • Genetic mechanisms of critical illness in Covid-19.

    E. Pairo-Castineira;E. Pairo-Castineira;S. Clohisey;L. Klaric;A. D. Bretherick

  • Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome

    Thijs Kuiken;Ron A.M. Fouchier;Martin Schutten;Guus F. Rimmelzwaan

  • Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020.

    Anika Singanayagam;Monika Patel;Andre Charlett;Jamie Lopez Bernal

  • Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study

    Elizabeth Miller;Katja Hoschler;Pia Hardelid;Elaine Stanford

  • Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study.

    Anika Singanayagam;Anika Singanayagam;Anika Singanayagam;Seran Hakki;Jake Dunning;Jake Dunning;Kieran J Madon

  • COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study.

    Victoria Jane Hall;Victoria Jane Hall;Sarah Foulkes;Ayoub Saei;Nick Andrews;Nick Andrews

  • Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction

    V M Corman;I Eckerle;T Bleicker;A Zaki

  • SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).

    V J Hall;S Foulkes;A Charlett;A Atti

  • Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion

    Alexandra C. Walls;Xiaoli Xiong;Young Jun Park;M. Alejandra Tortorici;M. Alejandra Tortorici

  • Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study.

    Simon de Lusignan;Simon de Lusignan;Jienchi Dorward;Jienchi Dorward;Ana Correa;Ana Correa;Nicholas Jones

  • Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012.

    Alison Bermingham;M.A. Chand;C.S. Brown;C.S. Brown;E. Aarons

  • Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine : a randomised trial of two potential vaccines against H5N1 influenza

    Karl G Nicholson;Anthony E Colegate;Audino Podda;Iain Stephenson

  • Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial

    Jean-Louis Bresson;Christian Perronne;Odile Launay;Catherine Gerdil

  • Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study

    Andrew C Hayward;Ellen B Fragaszy;Ellen B Fragaszy;Alison Bermingham;Lili Wang

  • Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season.

    Adam Meijer;Angie Lackenby;Olav Hungnes;Bruno Lina

  • Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study

    MC Zambon;JD Stockton;JP Clewley;DM Fleming

  • Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein.

    Andrew D Davidson;Maia Kavanagh Williamson;Sebastian D Lewis;Deborah K Shoemark

  • Detection of Influenza Viruses Resistant to Neuraminidase Inhibitors in Global Surveillance during the First 3 Years of Their Use

    Arnold S. Monto;Jennifer L. McKimm-Breschkin;Catherine Macken;Alan W. Hampson

  • Cross-Reactivity to Highly Pathogenic Avian Influenza H5N1 Viruses after Vaccination with Nonadjuvanted and MF59-Adjuvanted Influenza A/Duck/Singapore/97 (H5N3) Vaccine: A Potential Priming Strategy

    Iain Stephenson;Iain Stephenson;Roberto Bugarini;Karl G. Nicholson;Audino Podda

  • Human metapneumovirus as a cause of community-acquired respiratory illness

    Joanne Stockton;Iain Stephenson;Douglas Fleming;Maria Zambon

  • European Influenza Surveillance Scheme. Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season

    Meijer A;Lackenby A;Hungnes O;Lina B

Frequent Co-Authors

Joanna Ellis
Joanna Ellis Public Health England
Richard Pebody
Richard Pebody Public Health England
Nick Andrews
Nick Andrews Salk Institute for Biological Studies
Mary Ramsay
Mary Ramsay UK Health Security Agency
Karl G. Nicholson
Karl G. Nicholson University of Leicester
Shamez N. Ladhani
Shamez N. Ladhani UK Health Security Agency
Wendy S. Barclay
Wendy S. Barclay Imperial College London
Jonathan S. Nguyen-Van-Tam
Jonathan S. Nguyen-Van-Tam University of Nottingham
Kevin E. Brown
Kevin E. Brown Public Health England
John Wood
John Wood National Institute for Biological Standards and Control

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in immunology, exploring related healthcare careers can broaden opportunities. Many aspiring professionals consider accelerated nurse practitioner programs, which offer a fast-track route for registered nurses to advance their clinical expertise. These programs emphasize practical skills and leadership, making them ideal for those looking to specialize in immunological care.

Additionally, individuals without a nursing background can pursue pathways like online RN programs for non nurses in Florida, designed to transition newcomers into registered nursing roles quickly and efficiently. Such programs are often flexible and accessible, catering to career changers.

For those seeking foundational nursing education, the easiest ABSN to get into offers a streamlined bachelor’s degree pathway. These programs typically have more inclusive admission criteria and can be completed in a shorter time frame, making them appealing for fast career advancement.

Alternatively, if a quicker entry into the healthcare workforce is preferred, the fastest and easiest LPN programs provide essential nursing skills with minimal prerequisites. LPNs often serve as valuable members of immunology-related healthcare teams, delivering critical patient support.

Best Scientists Citing Maria Zambon

Trending Scientists

Recently Published Articles